Ocular Adverse Events after Coronavirus Disease 2019 mRNA Vaccination

Cumulative incidence Cumulative dose Rate ratio
DOI: 10.1016/j.ophtha.2022.10.017 Publication Date: 2022-10-26T00:52:06Z